These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8060913)
21. Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblasts. Korting HC; Hülsebus E; Kerscher M; Greber R; Schäfer-Korting M Br J Dermatol; 1995 Jul; 133(1):54-9. PubMed ID: 7669640 [TBL] [Abstract][Full Text] [Related]
22. Arachidonic acid release and prostaglandin E2 synthesis as irritant index of surfactants in 3T6 fibroblast cultures. Moreno JJ Toxicology; 2000 Mar; 143(3):275-82. PubMed ID: 10755713 [TBL] [Abstract][Full Text] [Related]
23. In vitro skin irritation testing with human skin cell cultures. Osborne R; Perkins MA Toxicol In Vitro; 1991; 5(5-6):563-7. PubMed ID: 20732078 [TBL] [Abstract][Full Text] [Related]
24. Chromium- and nickel-induced cytotoxicity in normal and transformed human keratinocytes: an investigation of pharmacological approaches to the prevention of Cr(VI)-induced cytotoxicity. Little MC; Gawkrodger DJ; MacNeil S Br J Dermatol; 1996 Feb; 134(2):199-207. PubMed ID: 8746330 [TBL] [Abstract][Full Text] [Related]
25. Determination of interleukin-1alpha in human NCTC 2544 keratinocyte cells as a predictor of skin irritation from lysine-based surfactants. Sanchez L; Mitjans M; Infante MR; Vinardell MP Toxicol Lett; 2006 Nov; 167(1):40-6. PubMed ID: 16996234 [TBL] [Abstract][Full Text] [Related]
26. A critical evaluation of predicting ocular irritancy potential from an in vitro cytotoxicity assay. Kennah HE; Albulescu D; Hignet S; Barrow CS Fundam Appl Toxicol; 1989 Feb; 12(2):281-90. PubMed ID: 2714528 [TBL] [Abstract][Full Text] [Related]
27. New cationic nanovesicular systems containing lysine-based surfactants for topical administration: Toxicity assessment using representative skin cell lines. Nogueira DR; Morán MC; Mitjans M; Martínez V; Pérez L; Vinardell MP Eur J Pharm Biopharm; 2013 Jan; 83(1):33-43. PubMed ID: 23032312 [TBL] [Abstract][Full Text] [Related]
28. Keratinocyte-derived proinflammatory key mediators and cell viability as in vitro parameters of irritancy: a possible alternative to the Draize skin irritation test. Müller-Decker K; Fürstenberger G; Marks F Toxicol Appl Pharmacol; 1994 Jul; 127(1):99-108. PubMed ID: 8048060 [TBL] [Abstract][Full Text] [Related]
29. Surfactant-induced skin irritation and skin repair. Evaluation of the acute human irritation model by noninvasive techniques. Wilhelm KP; Freitag G; Wolff HH J Am Acad Dermatol; 1994 Jun; 30(6):944-9. PubMed ID: 8188884 [TBL] [Abstract][Full Text] [Related]
30. Development and intralaboratory evaluation of an in vitro human cell-based test to aid ocular irritancy assessments. Osborne R; Perkins MA; Roberts DA Fundam Appl Toxicol; 1995 Nov; 28(1):139-53. PubMed ID: 8566478 [TBL] [Abstract][Full Text] [Related]
31. Use of XTT-assay to assess the cytotoxicity of different surfactants and metal salts in human keratinocytes (HaCaT). A feasible method for in vitro testing of skin irritants. Brosin A; Wolf V; Mattheus A; Heise H Acta Derm Venereol; 1997 Jan; 77(1):26-8. PubMed ID: 9059672 [TBL] [Abstract][Full Text] [Related]
32. Toxicity evaluation of the photoprotective compound LQFM048: Eye irritation, skin toxicity and genotoxic endpoints. de Ávila RI; de Sousa Vieira M; Gaeti MP; Moreira LC; de Brito Rodrigues L; de Oliveira GA; Batista AC; Vinhal DC; Menegatti R; Valadares MC Toxicology; 2017 Feb; 376():83-93. PubMed ID: 27129947 [TBL] [Abstract][Full Text] [Related]
33. In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Welss T; Basketter DA; Schröder KR Toxicol In Vitro; 2004 Jun; 18(3):231-43. PubMed ID: 15046769 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of surfactant cytotoxicity potential by primary cultures of ocular tissues: I. Characterization of rabbit corneal epithelial cells and initial injury and delayed toxicity studies. Grant RL; Yao C; Gabaldon D; Acosta D Toxicology; 1992 Nov; 76(2):153-76. PubMed ID: 1281345 [TBL] [Abstract][Full Text] [Related]
35. Prediction of eye irritancy potential of surfactants by cytotoxicity tests in vitro on cultures of human skin fibroblasts and keratinocytes. Cornelis M; Dupont C; Wepierre J Toxicol In Vitro; 1992 Mar; 6(2):119-28. PubMed ID: 20732101 [TBL] [Abstract][Full Text] [Related]
36. Ocular irritation: microscopic changes occurring over time in the rat with surfactants of known irritancy. Maurer JK; Parker RD; Carr GJ Toxicol Pathol; 1998; 26(2):217-25. PubMed ID: 9547859 [TBL] [Abstract][Full Text] [Related]
37. Use of human skin cell cultures for the estimation of potential skin irritants. Gueniche A; Ponec M Toxicol In Vitro; 1993 Jan; 7(1):15-24. PubMed ID: 20732167 [TBL] [Abstract][Full Text] [Related]
38. Changes in hydration of the stratum corneum are the most suitable indicator to evaluate the irritation of surfactants on the skin. Fujimura T; Shimotoyodome Y; Nishijima T; Sugata K; Taguchi H; Moriwaki S Skin Res Technol; 2017 Feb; 23(1):97-103. PubMed ID: 27500370 [TBL] [Abstract][Full Text] [Related]
39. Mechanistic-based non-animal assessment of eye toxicity: Inflammatory profile of human keratinocytes cells after exposure to eye damage/irritant agents. da Silva ACG; Chialchia AR; de Ávila RI; Valadares MC Chem Biol Interact; 2018 Aug; 292():1-8. PubMed ID: 29953848 [TBL] [Abstract][Full Text] [Related]
40. Potential irritation of lysine derivative surfactants by hemolysis and HaCaT cell viability. Sanchez L; Mitjans M; Infante MR; Vinardell MP Toxicol Lett; 2006 Feb; 161(1):53-60. PubMed ID: 16135402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]